Wouter Van Der Linden

Title: Wouter Van Der Linden: Innovator in Pharmaceutical Modulation

Introduction

Wouter Van Der Linden is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of IL-17A, which is crucial for treating various inflammatory conditions.

Latest Patents

Wouter holds four patents, with his latest innovations focusing on substituted benzenecarboxamides as IL-17A modulators. These compounds and pharmaceutical compositions are designed to treat inflammatory conditions such as psoriasis. Another of his recent patents involves novel IL-17 ligands and their pharmaceutical compositions, which also modulate IL-17A. These compounds may be beneficial in treating or preventing inflammation, cancer, or autoimmune diseases.

Career Highlights

Wouter is currently associated with Dice Alpha, Inc., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapeutic strategies that address significant health challenges.

Collaborations

Wouter has collaborated with esteemed colleagues such as Paul Ross Fatheree and Martin Sheringham Linsell, contributing to a dynamic research environment that fosters innovation.

Conclusion

Wouter Van Der Linden's contributions to pharmaceutical modulation highlight his role as a key innovator in the field. His work continues to pave the way for advancements in treating inflammatory conditions and other diseases.